Matches 1 - 50 out of 53 1 2 >


Match Document Document Title
US20140242184 Compositions for Regenerating Defective or Absent Myocardium  
Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an...
US20130344163 UMBILICAL CORD PRODUCTS  
Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
US20110206776 METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS  
Provided herein is a placental product comprising an immunocompatible amniotic membrane. Such placental products can be cryopreserved and contain viable therapeutic cells after thawing. The...
US20160303171 UMBILICAL CORD AMNIOTIC MEMBRANE PRODUCTS  
Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
US20150086573 BIRTH TISSUE MATERIAL AND METHOD OF PREPARATION  
A placental construct for treatment of a disease or condition is provided. The placental construct includes a therapeutically effective amount of a birth tissue material.
US20160106785 UMBILICAL CORD PRODUCTS  
Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
US20140255496 MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME  
Described herein are compositions composed of micronized placental components, extracts of micronized placental components, and pharmaceutical compositions thereof. The compositions have numerous...
US20160184368 UMBILICAL CORD AMNIOTIC MEMBRANE PRODUCTS  
Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
US20160038644 Compositions for Regenerating Defective or Absent Myocardium  
Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an...
US20150250829 MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME  
Described herein are compositions composed of micronized placental components, extracts of micronized placental components, and pharmaceutical compositions thereof. The compositions have numerous...
US20090041855 THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES  
A therapeutic agent for ophthalmic diseases containing Laennec (trade name) as an active ingredient. Laennec, the active ingredient, exhibits a therapeutic effect on a wide variety of ophthalmic...
US20120114712 UMBILICAL CORD BIOMATERIAL FOR MEDICAL USE  
The present invention provides a biomaterial comprising a mammalian umbilical cord membrane. The biomaterial can additionally comprise Wharton's jelly and/or one or more umbilical cord vessels....
US20150202235 Amnion-derived cell compositions, methods of making and uses thereof  
The invention is directed to substantially purified amnion-derived cell populations, compositions comprising the substantially purified amnion-derived cell populations, and to methods of creating...
US20120141595 UMBILICAL CORD AMNIOTIC MEMBRANE PRODUCTS  
Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.
US20080131522 Use of placental biomaterial for ocular surgery  
The present application is directed to a method of performing ocular surgery using biomaterial from placenta and/or umbilical cord, wherein the biomaterial is contacted with a tissue of the eye,...
US20170027993 METHODS OF INDUCING CELL DIFFERENTIATION WITH PLACENTAL EXTRACTS  
Disclosed are methods of preparing and using placentally-derived stem cells and compositions useful for the treatment of cancer. Said stem cells and compositions function through inducing a...
US20160067287 MICRONIZED PLACENTAL TISSUE COMPOSITIONS WITH OPTIONAL SEALANT AND METHODS OF MAKING AND USING THE SAME  
Described herein are compositions composed of micronized placental components and optionally a sealant, and pharmaceutical compositions thereof. Also described are systems, apparatuses, and...
US20130156863 METHODS OF PREPARING CHORION TISSUE AND PRODUCTS DERIVED THEREFROM  
Disclosed herein, in certain instances, are tissue grafts derived from chorion or amnio-chorion. Further disclosed herein, in certain instances, are use for tissue grafts derived from chorion or...
US20120276215 Therapeutic Conditioned Media  
Disclosed are therapeutic compositions useful for treatment of degenerative, autoimmune, inflammatory, and neurological conditions. In one embodiment, clinical conditions are treated by...
US20120195969 TREATMENT OF ACNE BY CONDITIONED MEDIA  
Disclosed are methods and compositions for treatment of acne or acneform conditions, particularly but not limited to, acne vulgaris with products generated from culture of stem or progenitor...
US20110070313 METHODS OF INDUCING CELL DIFFERENTIATION WITH PLACENTAL EXTRACTS  
Disclosed are methods of preparing and using placentally-derived stem cells and compositions useful for the treatment of cancer. Said stem cells and compositions function through inducing a...
US20160008410 MICRONIZED WHARTON'S JELLY  
The present invention provides compositions and formulations of micronized Wharton's jelly having a controlled viscosity such that when delivered to the injured region of a subject, it remains...
US20120156230 TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING PLACENTAL STEM CELLS  
Provided herein are methods of treatment of individuals having an injury to the central nervous system, such as a spinal cord injury or a traumatic brain injury, using placental stem cells and...
US20110038853 Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis  
The present invention relates to novel pharmaceutical or cosmetic compositions comprising at least one inhibitor of a sub-unit of AP-1 adaptor complex, of a kinesin interacting with AP-1, in...
US20160101135 Method and Composition for Hypothermic Storage of Placental Tissue  
A tissue storage solution includes hypothermic storage compositions and methods. The hypothermic storage composition includes media containing Dulbecco's modified Eagle's medium (DMEM) and...
US20130095061 UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF  
Compositions including topical formulations comprising secreted products obtained from the culture medium of human umbilical cord stem cells and particular combinations of components therefrom are...
US20160030487 METHODS FOR SELECTION OF AGE-APPROPRIATE TISSUES  
Methods of producing tissue matrices are provided. The methods can comprise selection of collagen-based tissues from animals based on desired mechanical and/or biologic properties relating to the...
US20150086634 COSMETIC USES OF MOLDED PLACENTAL COMPOSITIONS  
Described herein are methods of using molded dehydrated placental compositions, and cosmetic compositions thereof. The compositions have numerous cosmetic applications.
US20140271776 Preparations Derived From Placental Materials and Methods of Making and Using Same  
Preparations derived from placental materials and methods of making and using same, the preparations including a first preparation composed of placental membranes digested in collagenase, a second...
US20160095307 METHOD AND COMPOSITION FOR HYPOTHERMIC STORAGE OF PLACENTAL TISSUE  
A tissue storage solution includes hypothermic storage compositions and methods. The hypothermic storage composition includes media containing Dulbecco's modified Eagle's medium (DMEM) and...
US20160120912 COMPOSITIONS AND METHOD FOR PROMOTING NERVE GROWTH AND REGENERATION  
The invention relates generally to the fields of biology and health sciences. More particularly, the invention relates to compositions and methods for modulating cellular physiology and...
US20080075787 Therapeutic Agent For Ophthalmic Diseases  
A therapeutic agent for ophthalmic diseases containing Laennec (trade name) as an active ingredient. Laennec, the active ingredient, exhibits a therapeutic effect on a wide variety of ophthalmic...
US20120258083 PLACENTAL VASCULAR LOBULE STEM CELLS  
The present invention provides isolated populations of stem and progenitor cells from fetal vascular lobules of the placenta. The isolated populations of stem and progenitor cells of the invention...
US20080268007 Beauty/medication patch  
A beauty/medication patch including a substrate, an outer layer, and a medication lotion; the outer layer being made of a degradable material being disposed on the substrate; one or a plurality of...
US20110158958 Methods for treating ophthalmic disorders, diseases and injuries  
The invention is directed to methods for treating ophthalmic disorders, diseases and injuries. In particular, the invention is directed to treating disorders, diseases and injuries of the cornea...
US20150313948 TREATING ORAL LESIONS USING PLACENTAL EXTRACELLULAR MATRIX  
Provided herein are uses of compositions comprising extracellular matrix (ECM) and compositions comprising ECM components in the treatment of non-dental oral lesions.
US20120315259 METHOD AND COMPOSITION FOR SKIN CARE COMPRISING CORD BLOOD SERUM OR PLASMA OR COMPONENTS THEREOF  
A method and composition for treating dermatological conditions and improving skin condition and helping hair to grow or thicken involves removing extracts including beneficial secretions from...
US20140335046 Compositions, Methods and Systems for Regenerative Cosmetics  
A method of inducing or promoting hair growth on the scalp of a subject, comprising the steps of (i) providing an ECM composition including at least one ECM material, (ii) administering inciting...
US20130251670 Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof  
Described are methods of treating macular edema, as well as other complications of ocular inflammation, through the administration of various stem cell populations and conditioned media thereof....
US20090232784 ENDOTHELIAL PREDECESSOR CELL SEEDED WOUND HEALING SCAFFOLD  
Compositions and processes for promoting wound healing are provided by the present invention which increase the rate and completeness of wound healing. Broadly described, an inventive composition...
US20120009271 METHOD OF DISEASE-INDUCED AND RECEPTOR-MEDIATED STEM CELL NEUROPROTECTION  
Stem cells are exposed to disease condition (the OGD stroke model), that mimics the target disease (stroke), allowing the stem cells to exert better neuroprotective effects. Thus, the present...
US20160074773 METHOD FOR SEPARATING AND PURIFING FUNCTIONAL INGREDIENTS FROM PLACENTA USING SUPERCRITICAL FLUID TECHNOLOGY  
The present invention provides a method to separate and purify functional ingredients in placenta using supercritical fluid technology, where, placenta extract liquid and supercritical CO2 solvent...
US20160287750 STANDARDIZED AMNIOTIC MEMBRANE TISSUE GRAFT  
The invention relates to preparations of amniotic membrane-derived tissue grafts standardized for the concentration amniotic membrane and its constituent components by dry weight. The standardized...
US20130309317 FOOD SUPPLEMENT INCREASE CD34 STEM CELLS AND TELOMERASE ACTIVITY  
The present invention provides a food supplement, which comprises: a placental extract and an oil; which would promote the proliferation of CD34+ stem cells and increase the telomerase activity to...
US20160287749 RECONSTITUTED AMNIOTIC MEMBRANE-AMNIOTIC FLUID COMBINATION TISSUE GRAFT  
The invention relates to preparations and methods of creating preparations of reconstituted amniotic membrane utilizing amniotic fluid, for use as combination tissue grafts in surgical and...
US20150079061 METHOD FOR THE HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT  
The invention provides a method of harvesting, processing and storing a plurality of proteins from a mammalian feto-placental unit. The method includes dissecting a mammalian uterus to harvest at...
US20130243882 PHARMACEUTICAL COMPOSITION FOR TREATING SKIN WOUND  
The present invention provides a method for treating a skin wound in a subject, which comprises administering the skin wound with a composition comprising umbilical mesenchymal stem cells. More...
US20160175364 TROPHOBLAST DERIVED MICROPARTICLES FOR TREATING ISCHEMIC TISSUE AND WOUNDS  
The invention relates to pharmaceutical compositions comprising trophoblast derived microparticles for the treatment of damaged tissue, including, ischemic tissue and wounds.
US20160051591 METHOD FOR THE SEPARATION OF FUNCTIONAL INGREDIENTS IN PLACENTA  
The present invention provides a method for the separation of placenta functional ingredients. By using the supercritical fluid technology, the placenta powder is placed inside an extraction tank,...
US20150079062 METHOD FOR HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT  
The invention provides a method of harvesting, processing and storing a plurality of proteins from a mammalian feto-placental unit. The method includes dissecting a mammalian uterus to harvest at...

Matches 1 - 50 out of 53 1 2 >